Strata Critical Medical (SRTA) Director Philip M Receives RSU Award

What Happened

• Philip Edward M, a director of Strata Critical Medical, received an award of 30,913 Restricted Stock Units (RSUs) on 2026-07-30. The Form 4 reports an acquisition price of $0.00 per RSU (total $0), since these are compensation awards that convert into shares upon vesting. This is an award/grant transaction (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-30; Form 4 filed: 2026-08-03 (filed within the two-business-day window for a 7/30 transaction).
• Security: RSUs that will be settled in the issuer's common stock upon vesting.
• Quantity: 30,913 RSUs; price reported: $0.00 per RSU; reported aggregate acquisition value: $0.
• Vesting: 100% of the RSUs vest on the date of the Issuer's 2027 Annual Meeting of Stockholders (per footnote).
• Shares owned after transaction: not specified on the provided summary of the Form 4.
• Transaction code: A (award/grant).

Context

• RSU grants are a form of compensation and do not require the insider to pay cash now; they convert to shares only when they vest. Such awards are typically intended for retention or compensation and do not by themselves signal buying or selling intent.